Authors:
Refolo, LM
Pappolla, MA
LaFrancois, J
Malester, B
Schmidt, SD
Thomas-Bryant, T
Tint, GS
Wang, R
Mercken, M
Petanceska, SS
Duff, KE
Citation: Lm. Refolo et al., A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenicmouse model of Alzheimer's disease, NEUROBIOL D, 8(5), 2001, pp. 890-899
Citation: Ss. Petanceska et al., Ovariectomy and 17 beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain, EXP GERONT, 35(9-10), 2000, pp. 1317-1325
Citation: Ss. Petanceska et al., Ovariectomy and 17 beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain, NEUROLOGY, 54(12), 2000, pp. 2212-2217
Authors:
Petanceska, SS
Seeger, M
Checler, F
Gandy, S
Citation: Ss. Petanceska et al., Mutant presenilin 1 increases the levels of Alzheimer amyloid beta-peptideA beta 42 in late compartments of the constitutive secretory pathway, J NEUROCHEM, 74(5), 2000, pp. 1878-1884
Authors:
Liuzzo, JP
Petanceska, SS
Moscatelli, D
Devi, LA
Citation: Jp. Liuzzo et al., Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions, MOL MED, 5(5), 1999, pp. 320-333
Citation: Jp. Liuzzo et al., Neurotrophic factors regulate cathepsin S in macrophages and microglia: A role in the degradation of myelin basic protein and amyloid beta peptide, MOL MED, 5(5), 1999, pp. 334-343
Citation: Ss. Petanceska et S. Gandy, The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein, J NEUROCHEM, 73(6), 1999, pp. 2316-2320